[1]牛静 金新 马卉 侯萍 辛微 马利祥.冠心病患者PCI术后康复强度-时间依从性轨迹及预测因素分析[J].心血管病学进展,2024,(10):935.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.014]
　NIU JingJIN XinMA HuiHOU PingXIN WeiMA Lixiang.Analysis of Rehabilitation Intensity-Time Adherence Trajectories and?redictive Factors In Patients With Coronary Heart Disease After PCI[J].Advances in Cardiovascular Diseases,2024,(10):935.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.014]
点击复制

冠心病患者PCI术后康复强度-时间依从性轨迹及预测因素分析()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2024年10期
页码:
935
栏目:
论著
出版日期:
2024-10-25

文章信息/Info

Title:
Analysis of Rehabilitation Intensity-Time Adherence Trajectories and?redictive Factors In Patients With Coronary Heart Disease After PCI
作者:
牛静1 金新 2 马卉 1 侯萍 1 辛微 1 马利祥 1
(1.秦皇岛市第一医院导管室,河北 秦皇岛 066000;2.秦皇岛市第一医院心脏康复科,河北 秦皇岛 066000)
Author(s):
NIU Jing1JIN Xin2MA Hui1HOU Ping1XIN Wei1MA Lixiang1
?1.The First Hospital of Qinhuangdao,Qinhuangdao 066000,Hebei,China;2.Department of Cardiac Rehabilitation,The First Hospital of Qinhuangdao,Qinhuangdao 066000,Hebei,China)
关键词:
冠心病; 经皮冠状动脉介入治疗; 康复强度-时间依从性; 轨迹; 预测因素
Keywords:
Coronary heart disease; Percutaneous coronary intervention; Rehabilitation intensity-time compliance; Trajectory; Predictive factor
DOI:
10.16806/j.cnki.issn.1004-3934.2024.10.014
摘要:
目的 探究冠心病患者经皮冠状动脉介入治疗（PCI）术后康复强度-时间依从性轨迹及其预测因素。方法 选择2022年4月—2023年4月于秦皇岛市第一医院行PCI的冠心病患者120例为研究对象，进行为期1年的随访，使用运动日志记录监测强度-时间依从性。使用潜类别增长模型（LCGM）确定术后康复强度-时间依从性的发展轨迹。logistic回归分析不同轨迹类别的预测因素。结果 LCGM将患者术后康复强度-时间依从性变化分为低-下降组（n＝35，29.17%）、高-上升组（n＝15，12.50%）、持续依从组（n＝70，58.33%）。以低-下降组为参照组，高-上升组和持续依从组患者年龄更大、病程更短、病变程度更轻、心功能分级更低、抑郁程度更轻（P＜0.05）；持续依从组患者的医患关系更好（P＜0.05）。结论 冠心病患者PCI术后康复强度-时间依从性呈多类别曲线增长趋势，根据其时变特点及影响因素，实施强化干预，可提高患者康复依从性水平。
Abstract:
Objective Explore the coronary heart disease patients with percutaneous coronary intervention (PCI) postoperative rehabilitation intensity-time adherence trajectory and the forecast factors. Methods A total of 120 patients with coronary heart disease who underwent PCI in the First Hospital of Qinhuangdao from April 2022 to April 2023 were selected as the research objects. They were followed up for a period of one year. The exercise diary was used to monitor the intensive-time compliance. Latent class growth model (LCGM) was used to determine the development trajectory of postoperative rehabilitation intensity-time compliance. Logistic regression was used to analyze the predictors of different trajectory categories. Results According to LCGM,the changes of postoperative rehabilitation intensity-time compliance of patients were divided into low-decline group (n＝35,29.17%),high-rise group (n＝15,12.50%),and continuous compliance group (n＝70,58.33%). Patients in the low-descending group as the reference group,the high-ascending group and the continuous compliance group had older age,shorter disease course,less pathological degree,lower cardiac function grade and less depression degree (P＜0.05);patients in the continuous compliance group had better doctor-patient relationship (P＜0.05). Conclusion The rehabilitation intension-time compliance of patients with coronary heart disease after PCI shows a multi-category curve growth trend. According to its time-varying characteristics and influencing factors,the implementation of intensive intervention can improve the rehabilitation compliance of patients

参考文献/References:

[1].He Q,Ming D,Chen D,et al. Correlation of osteoprotegerin,sRANKL,inflammatory factors and epicardial adipose tissue volume with coronary heart disease[J]. Int J Clin Pract,2021,75(7):e14207.
[2].Marston NA,Vassy JL. A tale of two scores:comparing coronary artery calcium and polygenic risk scores for the prediction of coronary heart disease events[J]. Clin Chem,2024,70(2):358-360.
[3].Wu S,Qiu Z,Lu Y,et al. Predictive value of ACEF Ⅱ score for adverse prognosis in patients with coronary heart disease after percutaneous coronary intervention[J]. Postgrad Med J ,2022,99(1172):605-612.
[4].Xie Q,Huang J,Zhu K,et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus:cumulative meta-analysis[J]. Clin Cardiol,2021,44(7):899-906. Tsygankova O ,Ponkin S,Veretyuk V. Effect of mobile applications for physical activity tracking on exercise tolerance in patients with hypertension and coronary artery disease[J]. J Hypertens,2022,40(1):163-163.
[5].叶玲燕,陈圆圆,金丽红,等. 云平台联合早期康复训练在经皮冠状动脉介入治疗术后运动康复高危患者中的应用[J]. 中华护理杂志,2022,57(23):2851-2856.
[6].袁玮,聂姗,贾楠,等. 运动康复对经皮冠状动脉介入术后急性冠状动脉综合征患者的效果[J]. 中国康复理论与实践,2021,27(2):208-215.
[7].王洁,孙国珍,杨刚,等. 互联网+居家心脏康复模式下心房颤动射频消融术后患者运动康复依从性的动态轨迹研究[J]. 中国全科医学,2021,24(32):4074-4093.
[8].王洁,孙国珍,鲍志鹏,等. 心房颤动患者射频消融术后居家运动康复强度-时间依从性轨迹及预测因素的纵向研究[J]. 中国全科医学,2024,27(2):168-176,183.
[9].中华医学会心血管病学分会介入心脏病学组,动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等． 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志,2018,46(9):680-694．
[10].汤莉娅. 心脏疾病运动恐惧量表的汉化及其在冠心病患者中的应用研究[D]. 长春:吉林大学,2020.
[11].Xin F,Li Q,Guan F,et al. The study on psychological resilience of tinnitus and associated influencing factors[J]. J Otol,2021,17(1):13-17.
[12].Bahrami HSZ,Hasselbalch RB,S?holm H,et al. First-in-man trial of β3-adrenoceptor agonist treatment in chronic heart failure:impact on diastolic function[J]. J Cardiovasc Pharm,2024,83(5):466-473.
[13].Li J,Sun R. An observation study of the effect of “Internet + Nursing” on psychological status and quality of life of patients with thyroid eye disease[J]. Medicine (Baltimore),2024,103(17):37974.
[14].林嘉滢,涂舒婷,林嘉莉,等. 不同年龄脑卒中患者躯体感觉功能与运动功能相关性及全周期康复思考:一项多中心横断面研究[J]. 中国全科医学,2024,27(23):2838-2845.
[15].张世宇,刘鑫,宋冰雪,等. 高尿酸血症对合并高血压的ACS患者冠状动脉病变严重程度及PCI术后临床预后的影响[J]. 中国动脉硬化杂志,2022,30(5):416-422.
[16].冯靖,黄冬冬,陈伟杰,等. 术前预康复对前交叉韧带重建手术患者的影响[J]. 成都体育学院学报,2023,49(5):80-85.
[17].成静,白向威,于运福,等. 急性心肌梗死患者PCI术后外周血SIRT-1/NF-κB比值与心功能康复的关系[J]. 郑州大学学报(医学版),2021,56(6):841-844.
[18].陈凌辉,刘宗军,郜俊清,等. 运动康复对PCI术后患者心肺功能和预后的影响[J]. 临床心血管病杂志,2022,38(7):577-581.
[19].张文怡,南楠,高秉钰,等. 抑郁症状对冠心病患者远期预后的影响[J]. 中国循环杂志,2021,36(11):1083-1088.

相似文献/References:

[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
　DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(10):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
　NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(10):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
　LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(10):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
　YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(10):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
　SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(10):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
　GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(10):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
　DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(10):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
　CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(10):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
　YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(10):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
　GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(10):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[11]冯莉 林万鹏 郑丽婷 游紫阳 杨骄霞.经皮冠状动脉介入治疗后早期胸痛相关因素研究现状[J].心血管病学进展,2022,(11):1007.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.010]
　FENG Li,LIN Wanpeng,ZHENG Liting,et al.Research Status of Related Factors of Early Chest Pain After?ercutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(10):1007.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.010]
[12]林子健 许俊炜 陈剑 陈柏荣 罗礼云.血管内超声衰减斑块的研究进展[J].心血管病学进展,2023,(4):312.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.006]
　LIN Zijian,XU Junwei,CHEN Jian,et al.Attenuated Plaque Identified by Intravascular Ultrasound[J].Advances in Cardiovascular Diseases,2023,(10):312.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.006]

更新日期/Last Update: 2024-11-01